UNSPSC 51142502: Carbidopa

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H14N2O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MNX7R8C5VO, chemically known as hydrocinnamic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, l- but generally known as carbidopa, which bears US NIH Compound Identifier 2563. Carbidopa most often comes in base, anhydrous, and hydrate forms, and is often combined with Levodopa.

UNSPSC 51142502 Carbidopa, a Commodity code, shows significant mismatch between its pharmaceutical scope and the recent state and local solicitation activity posted under it. The code nominally covers carbidopa, a medication used in Parkinson's disease treatment, yet the three most recent opportunities tagged to this code involve athletic training services for municipal first-responders, general medical aid supplies for fire rescue, and a state pharmacy benefit program RFI focused on direct-to-manufacturer prescription fulfillment — none of which center on carbidopa procurement or pharmaceutical drug supply. The issuing bodies span city fire departments and police agencies (City of Tucson, City of Tampa Fire Rescue) and state health agencies (Texas Health and Human Services Commission), representing municipal public safety and state health administration rather than a coherent procurement family.

The geographic activity is limited to two states represented in recent opportunities — Arizona (Tucson) and Texas (HHS RFI) — with one opportunity from Florida (Tampa). The City of Tucson issued an RFP due June 9, 2026 for athletic training services to support injury prevention and rehabilitation for fire and police personnel, requiring NATA BOC and NSCA TSAC-F certified trainers with medical director oversight. The City of Tampa Fire Rescue issued an ITB (25P00157) due April 9, 2025 for medical aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, bandages, and first aid kits, with a $100,000 departmental budget and set-aside provisions for certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises. The Texas HHS Commission posted an RFI (HHS0017013) on April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs serving self-insured state employee health plans. The code shows little relevant recent activity aligned with carbidopa as a pharmaceutical commodity; the tagging appears to reflect categorization error rather than active state and local demand for the drug itself.